title: Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants.
authors.affiliation: Pediatric Transplantation, Children's Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, PA 15217, USA. sindhir@chplink.chp.edu
authors.forename: Rakesh
authors.initials: R
authors.lastname: Sindhi
authors.forename: J
authors.initials: J
authors.lastname: Ganjoo
authors.forename: W
authors.initials: W
authors.lastname: McGhee
authors.forename: G
authors.initials: G
authors.lastname: Mazariegos
authors.forename: J
authors.initials: J
authors.lastname: Reyes
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002648:Child; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016031:Liver Transplantation / Q000276:immunology*; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D012189:Retrospective Studies; D020123:Sirolimus / Q000008:administration & dosage / Q000627:therapeutic use*; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus